The Combined Effect of Polygenic Risk Score and Prostate Health Index in Chinese Men Undergoing Prostate Biopsy

The Combined Effect of Polygenic Risk Score and Prostate Health Index in Chinese Men Undergoing Prostate Biopsy

To date, the combined effect of polygenic risk score (PRS) and prostate health index (<i>phi</i>) on PCa diagnosis in men undergoing prostate biopsy has never been investigated. A total of 3166 patients who underwent initial prostate biopsy in three tertiary medical centers from August 2...

Full description

Bibliographic Details
Main Authors:	Xiaohao Ruan, Da Huang, Jingyi Huang, Jinlun Huang, Yongle Zhan, Yishuo Wu, Qiang Ding, Danfeng Xu, Haowen Jiang, Wei Xue, Rong Na
Format:	Article
Language:	English
Published:	MDPI AG 2023-02-01
Series:	Journal of Clinical Medicine
Subjects:	polygenic risk score prostate biopsy prostate cancer prostate health index prostate-specific antigen
Online Access:	https://www.mdpi.com/2077-0383/12/4/1343

Similar Items

Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes
by: Xiaohao Ruan, et al.
Published: (2023-07-01)

Is It Effective to Perform Two More Prostate Biopsies According to Prostate-Specific Antigen Level and Prostate Volume in Detecting Prostate Cancer? Prospective Study of 10-Core and 12-Core Prostate Biopsy
by: Byung Il Yoon, et al.
Published: (2012-05-01)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
by: Kwang Suk Lee, et al.
Published: (2017-03-01)

What Should Be the Prostate Specific Antigen Threshold for Prostate Biopsy?
by: Hasan Deliktaş, et al.
Published: (2017-06-01)

Effect of Finasteride on PSA and Histopathological Results in Patients Undergoing Prostate Biopsy
by: Saman Farshid, et al.
Published: (2022-12-01)

How to avoid prostate biopsy in men with Prostate Image-Reporting and Data System 3 lesion? Development and external validation of new biopsy indication using prostate health index density
by: Jae Yeon Kim, et al.
Published: (2023-09-01)

Prostate chronic inflammation type IV and prostate cancer risk in patients undergoing first biopsy set: Results of a large cohort study
by: Antonio Benito Porcaro, et al.
Published: (2015-10-01)

Acute prostatitis after prostate biopsy under ciprofloxacin prophylaxis with or without ornidazole and pre-biopsy enema: analysis of 3.479 prostate biopsy cases
by: Muhsin Balaban, et al.
Published: (2019-01-01)

Can we omit systematic biopsies in patients undergoing MRI fusion-targeted prostate biopsies?
by: Jeffrey J Leow, et al.
Published: (2023-01-01)

Morbidity following transperineal prostate biopsy: Our experience in 8.500 men
by: Pietro Pepe, et al.
Published: (2022-06-01)

Percentage of free prostate-specific antigen (PSA) is a useful method in deciding to perform prostate biopsy with higher core numbers in patients with low PSA cut-off values
by: Hasan Yilmaz, et al.
Published: (2015-06-01)

Prostate cancer detection rate in patients with fluctuating prostate-specific antigen levels on the repeat prostate biopsy
by: Yong Hyun Park, et al.
Published: (2014-03-01)

Addition of a Genetic Risk Score for Identification of Men with a Low Prostate-specific Antigen Level in Midlife at Risk of Developing Lethal Prostate Cancer
by: Chaoran Ma, et al.
Published: (2023-04-01)

Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy
by: Da Huang, et al.
Published: (2020-11-01)

Extended use of Prostate Health Index and percentage of [-2]pro-prostate-specific antigen in Chinese men with prostate specific antigen 10–20 ng/mL and normal digital rectal examination
by: Peter Ka-Fung Chiu, et al.
Published: (2016-09-01)

Assessment of PSA-Age volume score in predicting positive prostate biopsy findings in Turkey
by: Oktay Uçer, et al.
Published: (2015-10-01)

Establishment of two new predictive models for prostate cancer to determine whether to require prostate biopsy when the PSA level is in the diagnostic gray zone (4–10 ng ml−1)
by: Jun Liu, et al.
Published: (2020-01-01)

Effect on prostatic specific antigen by a short time treatment with a Curcuma extract: A real life experience and implications for prostate biopsy
by: Andrea Fabiani, et al.
Published: (2018-06-01)

A Study on TRUS-Guided Prostatic Biopsy and its Correlation with Serum PSA, Gleason Score and Grade-Grouping in a Tertiary Care Centre of Eastern India
by: GOPINATH BARUI, et al.
Published: (2019-03-01)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
by: Jeremy YC Teoh, et al.
Published: (2017-01-01)

Incidence of histological prostatitis and its correlation with PSA density
by: Affonso Celso Piovesan, et al.
Published: (2009-11-01)

Anterior prostate biopsy at initial and repeat evaluation: is it useful to detect significant prostate cancer?
by: Pietro Pepe, et al.
Published: (2015-10-01)

Nonspecific Presentation of a Multiloculated Prostatic Abscess After Transurethral Prostatic Biopsy for Elevated Prostate-specific Antigen Level
by: Nilay M. Gandhi, et al.
Published: (2014-11-01)

Evaluation of the pathologic results of prostate biopsies in terms of age, Gleason score and PSA level: Our experience and review of the literature
by: Selcuk Sarıkaya, et al.
Published: (2014-12-01)

Chronic inflammation of the prostate type IV with respect to risk of prostate cancer
by: Antonio B. Porcaro, et al.
Published: (2014-09-01)

Prostate cancer detection rate in Indonesian men
by: Chaidir Arif Mochtar, et al.
Published: (2018-03-01)

Changes in the outcome of prostate biopsies after preventive task force recommendation against prostate-specific antigen screening
by: Ahmed S. Zakaria, et al.
Published: (2018-08-01)

The Severity of Pain in Prostate Biopsy Depends on the Biopsy Sector
by: Grzegorz Rempega, et al.
Published: (2023-02-01)

Elevated prostate volume index and prostatic chronic inflammation reduce the number of positive cores at first prostate biopsy set: results in 945 consecutive patients
by: Antonio B. Porcaro, et al.

COMPARATIVE EVALUATION OF CURRENT METHODS OF ANESTHESIA IN PERFORMANCE OF TRANSRECTAL PROSTATE BIOPSY
by: M. E. Topuzov, et al.
Published: (2015-10-01)

Prostatic specific antigen for prostate cancer detection
by: Lucas Nogueira, et al.
Published: (2009-10-01)

Routine systematic prostate biopsies not replaced by magnetic resonance imaging-targeted biopsy
by: David Gómez-Ortiz, et al.
Published: (2022-10-01)

Multivariable Models Incorporating Multiparametric Magnetic Resonance Imaging Efficiently Predict Results of Prostate Biopsy and Reduce Unnecessary Biopsy
by: Shuanbao Yu, et al.
Published: (2020-11-01)

A review of transrectal ultrasound guided prostate biopsies: Is there still a role for finger guided prostate biopsies?
by: K.S. Jehle, et al.
Published: (2015-03-01)

Importance of prostate-specific antigen (PSA) as a predictive factor for concordance between the Gleason scores of prostate biopsies and RADICAL prostatectomy specimens
by: Nelson Gianni de Lima, et al.
Published: (2013-06-01)

Validity of Prostate Health Index and Percentage of [-2] Pro-Prostate-Specific Antigen as Novel Biomarkers in the Diagnosis of Prostate Cancer: Omani Tertiary Hospitals Experience
by: Safana S. Al Saidi, et al.
Published: (2017-07-01)

Value of various PSA parameters for diagnosing prostate cancer in men with normal digital rectal examination
by: Ari Miotto Jr, et al.
Published: (2004-04-01)

Histopathological Study of Prostatic Biopsies in Men with Prostatism
by: Kusuma Puttaswamy, et al.
Published: (2016-02-01)

A retrospective comparison between transrectal and transperineal prostate biopsy in the detection of prostate cancer
by: Carmelo Agostino Di Franco, et al.
Published: (2017-03-01)

Rebiopsy rate after transperineal or transrectal prostate biopsy
by: Jose L. Marenco Jimenez, et al.
Published: (2021-06-01)